SCHEDULE 7CONSEQUENTIAL AMENDMENTS TO REGULATIONS

20

In the Medicines (Advertising) Regulations 199451

a

in paragraph (1) of regulation 2, after the definition of “essential information” there shall be inserted the following definition—

  • “marketing authorization” means a marketing authorization granted by the European Commission under Council Regulation (EEC) No. 2309/93 or by the licensing authority under the Medicines for Human Use (Marketing Authorizations Etc.) Regulations 1994 and includes a product licence granted by the licensing authority under Part II of the Act;

b

in paragraph (1) of regulation 3, for the words “product licence” there shall be substituted the words “marketing authorization”; and

c

in regulation 4 for the words “product licence” there shall be substituted the words “marketing authorization”;

d

in sub-paragraph (l) of paragraph (1) of regulation 9, for the words “product licence” there shall be substituted the words “marketing authorization”;

e

in regulation 12, for the words “product licence” there shall be substituted the words “marketing authorization”; and

f

in Schedule 2—

i

in paragraph 1, for the word “licence” there shall be substituted the word “authorization”;

ii

in paragraph 2, for the words “product licence” there shall be substituted the words “marketing authorization”; and

iii

in paragraph 5, for the word “licence” there shall be substituted the word “authorization”; and